| Autor: |
Hoşoğlu, S, Gündeş, S, Kolaylõ, F, Karadenizli, A, Demirdağ, K, Günaydõn, M, Altõndis, M, Çaylan, R, Ucmak, H |
| Zdroj: |
Indian Journal of Medical Microbiology; October-December 2007, Vol. 25 Issue: 4 p346-350, 5p |
| Abstrakt: |
Purpose:To study the prevalence of TEM-, SHV- and GES-type β-lactamases among Escherichia coliand Klebsiella pneumoniaestrains having ceftazidime MICs higher than 2 mg/L. Methods:A total of 63 E. coliand 41 K. pneumoniaeisolated from five different university hospitals were studied for the existence of TEM-, SHV- and GES-type β-lactamases. Susceptibility tests were carried out according to the criteria of National Committee for Clinical Laboratory Standards. MICs were obtained by agar dilution method. Existence of extended-spectrum β-lactamases (ESBLs) were assessed by double-disc synergy test (DDST). Existence of the above-mentioned β-lactamase genes were studied both by PCR with specific oligonucleotide primers and isoelectric focusing methods. Results:None of the isolates were carbapenem-resistant. DDSTs were positive in 50 (79.3%) and 33 (80.5%) of E. coliand K. pneumoniae, respectively. TEM gene was detected in 41 (65.1%) and 19 (46.3%), whereas SHV gene in 18 (28.6%) and 20 (48.8%) of E. coliand K. pneumoniaestrains, respectively. GES genes were not detected. Conclusions:TEM and SHV genes are highly prevalent among ESBL-producing E. coliand K. pneumoniae, whereas GES-type ESBLs are absent and found not to be responsible of ceftazidime resistance in Turkish hospitals. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
Full Text from ScienceDirect